

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | sensory perception of smell (GO:0007608) | 7.26939433 |
| 2 | protein insertion into membrane (GO:0051205) | 5.51203478 |
| 3 | response to peptidoglycan (GO:0032494) | 4.73777679 |
| 4 | sarcomere organization (GO:0045214) | 4.64567099 |
| 5 | tricarboxylic acid cycle (GO:0006099) | 4.57546937 |
| 6 | negative regulation of interleukin-12 production (GO:0032695) | 4.47316545 |
| 7 | plasma membrane repair (GO:0001778) | 4.46698577 |
| 8 | neutrophil activation involved in immune response (GO:0002283) | 4.20887578 |
| 9 | sensory perception of chemical stimulus (GO:0007606) | 4.17131390 |
| 10 | NADH metabolic process (GO:0006734) | 4.14185553 |
| 11 | macrophage activation involved in immune response (GO:0002281) | 4.01208473 |
| 12 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 4.00498114 |
| 13 | negative regulation of cell killing (GO:0031342) | 4.00498114 |
| 14 | bundle of His cell to Purkinje myocyte communication (GO:0086069) | 3.88858276 |
| 15 | actin-myosin filament sliding (GO:0033275) | 3.85277406 |
| 16 | muscle filament sliding (GO:0030049) | 3.85277406 |
| 17 | modulation by symbiont of host immune response (GO:0052553) | 3.83398428 |
| 18 | positive regulation by symbiont of host defense response (GO:0052509) | 3.83398428 |
| 19 | modulation by symbiont of host defense response (GO:0052031) | 3.83398428 |
| 20 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.83398428 |
| 21 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.83398428 |
| 22 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.83398428 |
| 23 | negative regulation of potassium ion transmembrane transporter activity (GO:1901017) | 3.69528620 |
| 24 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.68261414 |
| 25 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 3.61309347 |
| 26 | detection of other organism (GO:0098543) | 3.55795235 |
| 27 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 3.53281428 |
| 28 | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO | 3.45170982 |
| 29 | negative regulation of potassium ion transmembrane transport (GO:1901380) | 3.41137121 |
| 30 | regulation of skeletal muscle contraction (GO:0014819) | 3.40777019 |
| 31 | 2-oxoglutarate metabolic process (GO:0006103) | 3.40455350 |
| 32 | detection of molecule of bacterial origin (GO:0032490) | 3.37712988 |
| 33 | creatine metabolic process (GO:0006600) | 3.37282339 |
| 34 | detection of bacterium (GO:0016045) | 3.36889463 |
| 35 | negative regulation of toll-like receptor 4 signaling pathway (GO:0034144) | 3.32685085 |
| 36 | myofibril assembly (GO:0030239) | 3.31675216 |
| 37 | ventricular cardiac muscle cell action potential (GO:0086005) | 3.30427290 |
| 38 | germinal center formation (GO:0002467) | 3.28120171 |
| 39 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.26814138 |
| 40 | glycosphingolipid catabolic process (GO:0046479) | 3.26425625 |
| 41 | immunoglobulin mediated immune response (GO:0016064) | 3.26046196 |
| 42 | cardiac muscle contraction (GO:0060048) | 3.25659822 |
| 43 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880) | 3.25014881 |
| 44 | fatty acid beta-oxidation (GO:0006635) | 3.24620164 |
| 45 | COPI coating of Golgi vesicle (GO:0048205) | 3.22570252 |
| 46 | Golgi transport vesicle coating (GO:0048200) | 3.22570252 |
| 47 | detection of external biotic stimulus (GO:0098581) | 3.21441050 |
| 48 | response to muramyl dipeptide (GO:0032495) | 3.21189979 |
| 49 | NIK/NF-kappaB signaling (GO:0038061) | 3.20851653 |
| 50 | cellular response to thyroid hormone stimulus (GO:0097067) | 3.20103919 |
| 51 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.19499798 |
| 52 | carnitine shuttle (GO:0006853) | 3.17536809 |
| 53 | negative regulation of cytokine production involved in immune response (GO:0002719) | 3.16473451 |
| 54 | aspartate family amino acid catabolic process (GO:0009068) | 3.14765195 |
| 55 | actin-mediated cell contraction (GO:0070252) | 3.14497578 |
| 56 | oxaloacetate metabolic process (GO:0006107) | 3.13299650 |
| 57 | glycogen catabolic process (GO:0005980) | 3.12635920 |
| 58 | biotin metabolic process (GO:0006768) | 3.09870757 |
| 59 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.09092855 |
| 60 | heart contraction (GO:0060047) | 3.08874426 |
| 61 | heart process (GO:0003015) | 3.08874426 |
| 62 | tricarboxylic acid metabolic process (GO:0072350) | 3.08247674 |
| 63 | positive regulation of triglyceride biosynthetic process (GO:0010867) | 3.08242539 |
| 64 | regulation of T-helper 2 cell differentiation (GO:0045628) | 3.05514044 |
| 65 | fatty acid transmembrane transport (GO:1902001) | 3.05297018 |
| 66 | granulocyte activation (GO:0036230) | 3.04681458 |
| 67 | ethanol oxidation (GO:0006069) | 3.04353458 |
| 68 | regulation of sequestering of triglyceride (GO:0010889) | 3.03437679 |
| 69 | sarcoplasmic reticulum calcium ion transport (GO:0070296) | 3.03363402 |
| 70 | cardiac myofibril assembly (GO:0055003) | 3.02011001 |
| 71 | cellular extravasation (GO:0045123) | 3.00382188 |
| 72 | sulfur amino acid catabolic process (GO:0000098) | 3.00321475 |
| 73 | regulation of mast cell degranulation (GO:0043304) | 2.99503238 |
| 74 | regulation of mononuclear cell migration (GO:0071675) | 2.98096428 |
| 75 | 4-hydroxyproline metabolic process (GO:0019471) | 2.97516371 |
| 76 | short-chain fatty acid metabolic process (GO:0046459) | 2.97180803 |
| 77 | T-helper 1 type immune response (GO:0042088) | 2.96580038 |
| 78 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 2.96023193 |
| 79 | antigen processing and presentation of endogenous antigen (GO:0019883) | 2.94616474 |
| 80 | amino sugar catabolic process (GO:0046348) | 2.94362545 |
| 81 | glycolipid catabolic process (GO:0019377) | 2.94289241 |
| 82 | regulation of interferon-beta biosynthetic process (GO:0045357) | 2.93123705 |
| 83 | oligosaccharide catabolic process (GO:0009313) | 2.92150709 |
| 84 | regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882) | 2.91988114 |
| 85 | low-density lipoprotein particle clearance (GO:0034383) | 2.90625234 |
| 86 | macrophage activation (GO:0042116) | 2.90371650 |
| 87 | lipid oxidation (GO:0034440) | 2.90004760 |
| 88 | regulation of vitamin D biosynthetic process (GO:0060556) | 2.89890305 |
| 89 | fatty acid oxidation (GO:0019395) | 2.89692821 |
| 90 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 2.87808733 |
| 91 | regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307) | 2.87326626 |
| 92 | glucan catabolic process (GO:0009251) | 2.87112452 |
| 93 | carnitine transmembrane transport (GO:1902603) | 2.86981379 |
| 94 | detection of biotic stimulus (GO:0009595) | 2.86961256 |
| 95 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 2.85973895 |
| 96 | positive regulation of chemokine biosynthetic process (GO:0045080) | 2.85271587 |
| 97 | type I interferon signaling pathway (GO:0060337) | 2.84325902 |
| 98 | cellular response to type I interferon (GO:0071357) | 2.84325902 |
| 99 | fatty acid catabolic process (GO:0009062) | 2.82701445 |
| 100 | positive regulation of cellular amide metabolic process (GO:0034250) | 2.82477744 |
| 101 | regulation of chromatin binding (GO:0035561) | 2.82344289 |
| 102 | response to type I interferon (GO:0034340) | 2.80911776 |
| 103 | regulation of gamma-delta T cell activation (GO:0046643) | 2.80448228 |
| 104 | lysine metabolic process (GO:0006553) | 2.79254370 |
| 105 | lysine catabolic process (GO:0006554) | 2.79254370 |
| 106 | neutrophil activation (GO:0042119) | 2.79231799 |
| 107 | regulation of leukocyte degranulation (GO:0043300) | 2.78071374 |
| 108 | defense response to protozoan (GO:0042832) | 2.78035371 |
| 109 | cell communication involved in cardiac conduction (GO:0086065) | 2.78033326 |
| 110 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 2.77458883 |
| 111 | regulation of podosome assembly (GO:0071801) | 2.77242207 |
| 112 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.77095285 |
| 113 | branched-chain amino acid catabolic process (GO:0009083) | 2.76812425 |
| 114 | myeloid dendritic cell differentiation (GO:0043011) | 2.76507680 |
| 115 | myeloid cell activation involved in immune response (GO:0002275) | 2.76190230 |
| 116 | amino-acid betaine transport (GO:0015838) | 2.76127203 |
| 117 | carnitine transport (GO:0015879) | 2.76127203 |
| 118 | barbed-end actin filament capping (GO:0051016) | 2.75887277 |
| 119 | acetyl-CoA metabolic process (GO:0006084) | 2.73467170 |
| 120 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 2.73420424 |
| 121 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 2.72724821 |
| 122 | ADP metabolic process (GO:0046031) | 2.72681351 |
| 123 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 2.71983095 |
| 124 | response to protozoan (GO:0001562) | 2.69657190 |
| 125 | regulation of acetyl-CoA biosynthetic process from pyruvate (GO:0010510) | 2.69016963 |
| 126 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 2.68872758 |
| 127 | cellular polysaccharide catabolic process (GO:0044247) | 2.68445919 |
| 128 | regulation of mast cell activation involved in immune response (GO:0033006) | 2.67954253 |
| 129 | striated muscle contraction (GO:0006941) | 2.66348493 |
| 130 | negative regulation of myeloid cell apoptotic process (GO:0033033) | 2.66011812 |
| 131 | ethanol metabolic process (GO:0006067) | 2.65970004 |
| 132 | mannose metabolic process (GO:0006013) | 2.65959188 |
| 133 | regulation of cilium movement (GO:0003352) | 2.65475886 |
| 134 | actomyosin structure organization (GO:0031032) | 2.65085172 |
| 135 | regulation of cytokine secretion involved in immune response (GO:0002739) | 2.62835801 |
| 136 | leukocyte aggregation (GO:0070486) | 2.62798040 |
| 137 | regulation of chemokine biosynthetic process (GO:0045073) | 2.61921805 |
| 138 | response to thyroid hormone (GO:0097066) | 2.61111027 |
| 139 | oxidative phosphorylation (GO:0006119) | 2.60536652 |
| 140 | protein localization to endosome (GO:0036010) | 2.60293176 |
| 141 | positive regulation of type 2 immune response (GO:0002830) | 2.59549858 |
| 142 | regulation of actin filament-based movement (GO:1903115) | 2.59289577 |
| 143 | regulation of heart rate by cardiac conduction (GO:0086091) | 2.59262492 |
| 144 | gluconeogenesis (GO:0006094) | 2.57893324 |
| 145 | positive regulation of triglyceride metabolic process (GO:0090208) | 2.57636002 |
| 146 | polysaccharide catabolic process (GO:0000272) | 2.57130483 |
| 147 | CDP-diacylglycerol metabolic process (GO:0046341) | 2.57104157 |
| 148 | positive regulation of antigen processing and presentation (GO:0002579) | 2.56723181 |
| 149 | regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314) | 2.56445011 |
| 150 | regulation of fatty acid oxidation (GO:0046320) | 2.56409237 |
| 151 | regulation of vascular endothelial growth factor signaling pathway (GO:1900746) | 2.55928790 |
| 152 | regulation of relaxation of muscle (GO:1901077) | 2.55767058 |
| 153 | regulation of antigen processing and presentation (GO:0002577) | 2.54851567 |
| 154 | N-acetylneuraminate metabolic process (GO:0006054) | 2.54702353 |
| 155 | negative regulation of innate immune response (GO:0045824) | 2.54473417 |
| 156 | respiratory burst (GO:0045730) | 2.54000869 |
| 157 | positive regulation of cholesterol efflux (GO:0010875) | 2.53479714 |
| 158 | negative regulation of production of molecular mediator of immune response (GO:0002701) | 2.52044548 |
| 159 | monocarboxylic acid catabolic process (GO:0072329) | 2.51951402 |
| 160 | ceramide catabolic process (GO:0046514) | 2.51891594 |
| 161 | monosaccharide biosynthetic process (GO:0046364) | 2.51652525 |
| 162 | negative regulation of interleukin-6 production (GO:0032715) | 2.51312610 |
| 163 | regulation of cholesterol metabolic process (GO:0090181) | 2.50102882 |
| 164 | valine metabolic process (GO:0006573) | 2.49042122 |
| 165 | regulation of macrophage chemotaxis (GO:0010758) | 2.49011603 |
| 166 | activation of signaling protein activity involved in unfolded protein response (GO:0006987) | 2.48778673 |
| 167 | branched-chain amino acid metabolic process (GO:0009081) | 2.48739849 |
| 168 | protein localization to cilium (GO:0061512) | 2.48395359 |
| 169 | cardiac muscle cell development (GO:0055013) | 2.48223836 |
| 170 | regulation of type 2 immune response (GO:0002828) | 2.47818529 |
| 171 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 2.47648992 |
| 172 | response to host immune response (GO:0052572) | 2.47648992 |
| 173 | hexose biosynthetic process (GO:0019319) | 2.46829361 |
| 174 | pinocytosis (GO:0006907) | 2.45983885 |
| 175 | carnitine metabolic process (GO:0009437) | 2.45581368 |
| 176 | acyl-CoA biosynthetic process (GO:0071616) | 2.44795104 |
| 177 | thioester biosynthetic process (GO:0035384) | 2.44795104 |
| 178 | regulation of cell communication by electrical coupling (GO:0010649) | 2.44766542 |
| 179 | myeloid dendritic cell activation (GO:0001773) | 2.44130600 |
| 180 | regulation of T cell tolerance induction (GO:0002664) | 2.43914826 |
| 181 | regulation of membrane protein ectodomain proteolysis (GO:0051043) | 2.43795836 |
| 182 | regulation of toll-like receptor 4 signaling pathway (GO:0034143) | 2.43489138 |
| 183 | regulation of tolerance induction (GO:0002643) | 2.43107976 |
| 184 | regulation of vitamin metabolic process (GO:0030656) | 2.43104241 |
| 185 | negative regulation of leukocyte mediated immunity (GO:0002704) | 2.42908073 |
| 186 | glycogen biosynthetic process (GO:0005978) | 2.42019839 |
| 187 | glucan biosynthetic process (GO:0009250) | 2.42019839 |
| 188 | regulation of cholesterol storage (GO:0010885) | 2.41260585 |
| 189 | CDP-diacylglycerol biosynthetic process (GO:0016024) | 2.41244940 |
| 190 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 2.41008481 |
| 191 | cardiac muscle cell action potential involved in contraction (GO:0086002) | 2.40013511 |
| 192 | regulation of acyl-CoA biosynthetic process (GO:0050812) | 2.39711855 |
| 193 | regulation of coenzyme metabolic process (GO:0051196) | 2.39386144 |
| 194 | regulation of cofactor metabolic process (GO:0051193) | 2.39386144 |
| 195 | positive regulation of mast cell activation (GO:0033005) | 2.38077273 |
| 196 | negative regulation of tumor necrosis factor production (GO:0032720) | 2.38023999 |
| 197 | negative regulation of toll-like receptor signaling pathway (GO:0034122) | 2.37401959 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 4.27443881 |
| 2 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 3.92455746 |
| 3 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 3.67970882 |
| 4 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 3.65081716 |
| 5 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 3.20032534 |
| 6 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.99195027 |
| 7 | ZNF263_19887448_ChIP-Seq_K562_Human | 2.82303478 |
| 8 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.79540858 |
| 9 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 2.76804290 |
| 10 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.75977961 |
| 11 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 2.72313056 |
| 12 | * RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 2.46165587 |
| 13 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.44604277 |
| 14 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 2.43391626 |
| 15 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 2.42343050 |
| 16 | VDR_24763502_ChIP-Seq_THP-1_Human | 2.23178346 |
| 17 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.22378341 |
| 18 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 2.17777961 |
| 19 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.14906831 |
| 20 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 2.07503764 |
| 21 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.06040032 |
| 22 | LXR_22292898_ChIP-Seq_THP-1_Human | 2.03509184 |
| 23 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 2.01814550 |
| 24 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.99316782 |
| 25 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.98613337 |
| 26 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.98523981 |
| 27 | SPI1_23127762_ChIP-Seq_K562_Human | 1.91007374 |
| 28 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.82442517 |
| 29 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.81865756 |
| 30 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.81746274 |
| 31 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.81746274 |
| 32 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.73112301 |
| 33 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.69308413 |
| 34 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.68043118 |
| 35 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.66340375 |
| 36 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.66334464 |
| 37 | * TCF7_22412390_ChIP-Seq_EML_Mouse | 1.65210634 |
| 38 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.63598619 |
| 39 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.62747343 |
| 40 | MAF_26560356_Chip-Seq_TH1_Human | 1.61346007 |
| 41 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.61077405 |
| 42 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.59990069 |
| 43 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.59290267 |
| 44 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.57887212 |
| 45 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.57285438 |
| 46 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.56184936 |
| 47 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.54543608 |
| 48 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.54498225 |
| 49 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.54051115 |
| 50 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.51874680 |
| 51 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.51665043 |
| 52 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.50267250 |
| 53 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 1.49922618 |
| 54 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.49223344 |
| 55 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.47013131 |
| 56 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.46065408 |
| 57 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 1.44750045 |
| 58 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.44242205 |
| 59 | ATF3_27146783_Chip-Seq_COLON_Human | 1.42388108 |
| 60 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 1.41241988 |
| 61 | P68_20966046_ChIP-Seq_HELA_Human | 1.40034620 |
| 62 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.39526661 |
| 63 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.39405508 |
| 64 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.39030561 |
| 65 | UTX_26944678_Chip-Seq_JUKART_Human | 1.37338299 |
| 66 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.36583537 |
| 67 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.36049734 |
| 68 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 1.35957506 |
| 69 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.34043406 |
| 70 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.34014292 |
| 71 | GATA3_20176728_ChIP-ChIP_TSCs_Mouse | 1.33581230 |
| 72 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.32886163 |
| 73 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 1.31327431 |
| 74 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.29984087 |
| 75 | * TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.28210408 |
| 76 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.28198546 |
| 77 | PHF8_20622854_ChIP-Seq_HELA_Human | 1.27289507 |
| 78 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.26711473 |
| 79 | MAF_26560356_Chip-Seq_TH2_Human | 1.26463720 |
| 80 | MYC_22102868_ChIP-Seq_BL_Human | 1.26170286 |
| 81 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.25649966 |
| 82 | E2F1_20622854_ChIP-Seq_HELA_Human | 1.25091858 |
| 83 | GATA1_19941826_ChIP-Seq_K562_Human | 1.23250912 |
| 84 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.22273153 |
| 85 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.22211573 |
| 86 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.21084627 |
| 87 | CTCF_20526341_ChIP-Seq_ESCs_Human | 1.21000782 |
| 88 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.20330014 |
| 89 | TP63_22573176_ChIP-Seq_HFKS_Human | 1.20067746 |
| 90 | KDM2B_26808549_Chip-Seq_K562_Human | 1.19900333 |
| 91 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 1.19216424 |
| 92 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.18738777 |
| 93 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.18554426 |
| 94 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.18195605 |
| 95 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.18081524 |
| 96 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.17659249 |
| 97 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.16819963 |
| 98 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.15096148 |
| 99 | RBPJ_21746931_ChIP-Seq_IB4-LCL_Human | 1.14384750 |
| 100 | OCT4_20526341_ChIP-Seq_ESCs_Human | 1.14081269 |
| 101 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.13918648 |
| 102 | * RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.13692603 |
| 103 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.13250922 |
| 104 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.12572967 |
| 105 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.11556379 |
| 106 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.10704033 |
| 107 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 1.09407599 |
| 108 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.09081141 |
| 109 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.08926869 |
| 110 | * PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 1.08288024 |
| 111 | FOXH1_21741376_ChIP-Seq_ESCs_Human | 1.07553545 |
| 112 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.07425850 |
| 113 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.06128749 |
| 114 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.06036581 |
| 115 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.05816003 |
| 116 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.04898725 |
| 117 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.04866695 |
| 118 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.04637562 |
| 119 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.03451934 |
| 120 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.03446307 |
| 121 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.02743609 |
| 122 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.02436274 |
| 123 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.02309771 |
| 124 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.01965500 |
| 125 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.01842680 |
| 126 | * TFEB_21752829_ChIP-Seq_HELA_Human | 1.01722543 |
| 127 | TAF2_19829295_ChIP-Seq_ESCs_Human | 1.01663139 |
| 128 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.00671782 |
| 129 | * TBX5_21415370_ChIP-Seq_HL-1_Mouse | 1.00383260 |
| 130 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.00317788 |
| 131 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.00229721 |
| 132 | SMC4_20622854_ChIP-Seq_HELA_Human | 0.99753301 |
| 133 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 0.99702904 |
| 134 | * SIN3A_21632747_ChIP-Seq_MESCs_Mouse | 0.99603703 |
| 135 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.99310292 |
| 136 | CTCF_21964334_Chip-Seq_Bcells_Human | 0.99306243 |
| 137 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 0.98884339 |
| 138 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 0.98686989 |
| 139 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 0.98256858 |
| 140 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 0.97571195 |
| 141 | VDR_21846776_ChIP-Seq_THP-1_Human | 0.96913771 |
| 142 | MEF2A_21415370_ChIP-Seq_HL-1_Mouse | 0.96310822 |
| 143 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.96031729 |
| 144 | EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 0.95494521 |
| 145 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 0.94629376 |
| 146 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.94306132 |
| 147 | SA1_27219007_Chip-Seq_Bcells_Human | 0.94201048 |
| 148 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.93722447 |
| 149 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.93353199 |
| 150 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 0.92419280 |
| 151 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.91772031 |
| 152 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 0.91554512 |
| 153 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.90272854 |
| 154 | TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.90040802 |
| 155 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 0.89763096 |
| 156 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 0.89687269 |
| 157 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 0.89479159 |
| 158 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 0.88555204 |
| 159 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 0.86313691 |
| 160 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 0.84985116 |
| 161 | * CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.84344206 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0001984_abnormal_olfaction | 5.02109931 |
| 2 | MP0003806_abnormal_nucleotide_metabolis | 4.33246970 |
| 3 | MP0003646_muscle_fatigue | 4.04079550 |
| 4 | MP0003303_peritoneal_inflammation | 4.02003808 |
| 5 | MP0005058_abnormal_lysosome_morphology | 3.95864645 |
| 6 | MP0002837_dystrophic_cardiac_calcinosis | 3.91571701 |
| 7 | MP0003724_increased_susceptibility_to | 3.27437218 |
| 8 | MP0000751_myopathy | 3.11423284 |
| 9 | MP0009840_abnormal_foam_cell | 3.06573020 |
| 10 | MP0004084_abnormal_cardiac_muscle | 2.99925476 |
| 11 | MP0000749_muscle_degeneration | 2.98027321 |
| 12 | MP0002148_abnormal_hypersensitivity_rea | 2.66880398 |
| 13 | MP0009785_altered_susceptibility_to | 2.65796685 |
| 14 | MP0002419_abnormal_innate_immunity | 2.64398733 |
| 15 | MP0004036_abnormal_muscle_relaxation | 2.59953762 |
| 16 | MP0001835_abnormal_antigen_presentation | 2.39404656 |
| 17 | MP0003300_gastrointestinal_ulcer | 2.37248594 |
| 18 | MP0005025_abnormal_response_to | 2.33993271 |
| 19 | MP0005000_abnormal_immune_tolerance | 2.30379974 |
| 20 | MP0000750_abnormal_muscle_regeneration | 2.28169015 |
| 21 | MP0005330_cardiomyopathy | 2.22875550 |
| 22 | MP0005387_immune_system_phenotype | 2.21964868 |
| 23 | MP0001790_abnormal_immune_system | 2.21964868 |
| 24 | MP0004087_abnormal_muscle_fiber | 2.16725069 |
| 25 | MP0001533_abnormal_skeleton_physiology | 2.16394941 |
| 26 | MP0004215_abnormal_myocardial_fiber | 2.16092453 |
| 27 | MP0002269_muscular_atrophy | 2.10217437 |
| 28 | MP0005670_abnormal_white_adipose | 2.07633696 |
| 29 | MP0000747_muscle_weakness | 2.01697314 |
| 30 | MP0005671_abnormal_response_to | 1.99124865 |
| 31 | MP0000685_abnormal_immune_system | 1.95743629 |
| 32 | MP0004130_abnormal_muscle_cell | 1.94531644 |
| 33 | MP0009278_abnormal_bone_marrow | 1.90808925 |
| 34 | MP0009764_decreased_sensitivity_to | 1.88704539 |
| 35 | MP0002452_abnormal_antigen_presenting | 1.85914495 |
| 36 | MP0003172_abnormal_lysosome_physiology | 1.85327452 |
| 37 | MP0002723_abnormal_immune_serum | 1.84930754 |
| 38 | MP0005083_abnormal_biliary_tract | 1.83444000 |
| 39 | MP0003195_calcinosis | 1.83388062 |
| 40 | MP0004947_skin_inflammation | 1.78447593 |
| 41 | MP0001800_abnormal_humoral_immune | 1.77867199 |
| 42 | MP0002998_abnormal_bone_remodeling | 1.76214701 |
| 43 | MP0008260_abnormal_autophagy | 1.73777830 |
| 44 | MP0002972_abnormal_cardiac_muscle | 1.71393934 |
| 45 | MP0000343_altered_response_to | 1.70466945 |
| 46 | MP0006036_abnormal_mitochondrial_physio | 1.70217230 |
| 47 | MP0003705_abnormal_hypodermis_morpholog | 1.68653303 |
| 48 | MP0002106_abnormal_muscle_physiology | 1.65520303 |
| 49 | MP0005365_abnormal_bile_salt | 1.62420012 |
| 50 | MP0002420_abnormal_adaptive_immunity | 1.61667154 |
| 51 | MP0001819_abnormal_immune_cell | 1.61000510 |
| 52 | MP0001845_abnormal_inflammatory_respons | 1.55136026 |
| 53 | MP0005464_abnormal_platelet_physiology | 1.54886929 |
| 54 | MP0010155_abnormal_intestine_physiology | 1.54869545 |
| 55 | MP0008469_abnormal_protein_level | 1.51268854 |
| 56 | MP0001853_heart_inflammation | 1.50813964 |
| 57 | MP0003186_abnormal_redox_activity | 1.49376561 |
| 58 | MP0002405_respiratory_system_inflammati | 1.43792998 |
| 59 | MP0005620_abnormal_muscle_contractility | 1.43755721 |
| 60 | MP0010630_abnormal_cardiac_muscle | 1.42563855 |
| 61 | MP0005166_decreased_susceptibility_to | 1.42559150 |
| 62 | MP0004858_abnormal_nervous_system | 1.42249264 |
| 63 | MP0003453_abnormal_keratinocyte_physiol | 1.41463029 |
| 64 | MP0000759_abnormal_skeletal_muscle | 1.41416029 |
| 65 | MP0005167_abnormal_blood-brain_barrier | 1.41277054 |
| 66 | MP0008004_abnormal_stomach_pH | 1.41128771 |
| 67 | MP0003566_abnormal_cell_adhesion | 1.41054570 |
| 68 | MP0000858_altered_metastatic_potential | 1.38540828 |
| 69 | MP0008775_abnormal_heart_ventricle | 1.37405670 |
| 70 | MP0005319_abnormal_enzyme/_coenzyme | 1.37186857 |
| 71 | MP0001542_abnormal_bone_strength | 1.36312616 |
| 72 | MP0005397_hematopoietic_system_phenotyp | 1.35704063 |
| 73 | MP0001545_abnormal_hematopoietic_system | 1.35704063 |
| 74 | MP0002254_reproductive_system_inflammat | 1.32428711 |
| 75 | MP0003191_abnormal_cellular_cholesterol | 1.30675288 |
| 76 | MP0001544_abnormal_cardiovascular_syste | 1.30619822 |
| 77 | MP0005385_cardiovascular_system_phenoty | 1.30619822 |
| 78 | MP0005369_muscle_phenotype | 1.29575213 |
| 79 | MP0002139_abnormal_hepatobiliary_system | 1.29467300 |
| 80 | MP0003448_altered_tumor_morphology | 1.27947202 |
| 81 | MP0004233_abnormal_muscle_weight | 1.27350881 |
| 82 | MP0009333_abnormal_splenocyte_physiolog | 1.26698721 |
| 83 | MP0005666_abnormal_adipose_tissue | 1.26024557 |
| 84 | MP0005332_abnormal_amino_acid | 1.25506857 |
| 85 | MP0008875_abnormal_xenobiotic_pharmacok | 1.23133558 |
| 86 | MP0005410_abnormal_fertilization | 1.22791577 |
| 87 | MP0005375_adipose_tissue_phenotype | 1.21479154 |
| 88 | MP0005310_abnormal_salivary_gland | 1.21377142 |
| 89 | MP0006054_spinal_hemorrhage | 1.21276202 |
| 90 | MP0004145_abnormal_muscle_electrophysio | 1.18093993 |
| 91 | MP0005165_increased_susceptibility_to | 1.16992866 |
| 92 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.16916418 |
| 93 | MP0003183_abnormal_peptide_metabolism | 1.15394181 |
| 94 | MP0004484_altered_response_of | 1.14454353 |
| 95 | MP0000003_abnormal_adipose_tissue | 1.14156227 |
| 96 | MP0005275_abnormal_skin_tensile | 1.13785264 |
| 97 | MP0003656_abnormal_erythrocyte_physiolo | 1.12997756 |
| 98 | MP0009643_abnormal_urine_homeostasis | 1.12964432 |
| 99 | MP0004510_myositis | 1.12081824 |
| 100 | MP0008438_abnormal_cutaneous_collagen | 1.11797289 |
| 101 | MP0002909_abnormal_adrenal_gland | 1.10215008 |
| 102 | MP0005164_abnormal_response_to | 1.09078606 |
| 103 | MP0000716_abnormal_immune_system | 1.08631492 |
| 104 | MP0003279_aneurysm | 1.06837076 |
| 105 | MP0004043_abnormal_pH_regulation | 1.04592491 |
| 106 | MP0005085_abnormal_gallbladder_physiolo | 1.04380125 |
| 107 | MP0005451_abnormal_body_composition | 1.03803668 |
| 108 | MP0000604_amyloidosis | 1.03782963 |
| 109 | MP0002118_abnormal_lipid_homeostasis | 1.03163376 |
| 110 | MP0003252_abnormal_bile_duct | 1.01668929 |
| 111 | MP0005390_skeleton_phenotype | 1.01175365 |
| 112 | MP0003137_abnormal_impulse_conducting | 1.00967194 |
| 113 | MP0005360_urolithiasis | 1.00616892 |
| 114 | MP0002332_abnormal_exercise_endurance | 0.99814813 |
| 115 | MP0004185_abnormal_adipocyte_glucose | 0.99012097 |
| 116 | MP0003221_abnormal_cardiomyocyte_apopto | 0.98061303 |
| 117 | MP0008789_abnormal_olfactory_epithelium | 0.95337560 |
| 118 | MP0003091_abnormal_cell_migration | 0.95001533 |
| 119 | MP0000920_abnormal_myelination | 0.94464188 |
| 120 | MP0004883_abnormal_blood_vessel | 0.93630393 |
| 121 | MP0010329_abnormal_lipoprotein_level | 0.92825449 |
| 122 | MP0006138_congestive_heart_failure | 0.89004235 |
| 123 | MP0001666_abnormal_nutrient_absorption | 0.88792644 |
| 124 | MP0002933_joint_inflammation | 0.88775653 |
| 125 | MP0002877_abnormal_melanocyte_morpholog | 0.87241920 |
| 126 | MP0000465_gastrointestinal_hemorrhage | 0.86558576 |
| 127 | MP0001851_eye_inflammation | 0.86294892 |
| 128 | MP0009763_increased_sensitivity_to | 0.86004728 |
| 129 | MP0002398_abnormal_bone_marrow | 0.85585133 |
| 130 | MP0003075_altered_response_to | 0.85390145 |
| 131 | MP0006035_abnormal_mitochondrial_morpho | 0.83518638 |
| 132 | MP0003634_abnormal_glial_cell | 0.81910233 |
| 133 | MP0002429_abnormal_blood_cell | 0.81165926 |
| 134 | MP0000609_abnormal_liver_physiology | 0.81144729 |
| 135 | MP0003828_pulmonary_edema | 0.81074524 |
| 136 | MP0003795_abnormal_bone_structure | 0.79629686 |
| 137 | MP0003690_abnormal_glial_cell | 0.79542104 |
| 138 | MP0000249_abnormal_blood_vessel | 0.79402086 |
| 139 | MP0008874_decreased_physiological_sensi | 0.79150063 |
| 140 | MP0005023_abnormal_wound_healing | 0.79045340 |
| 141 | MP0000358_abnormal_cell_content/ | 0.78354993 |
| 142 | MP0000689_abnormal_spleen_morphology | 0.78201486 |
| 143 | MP0003763_abnormal_thymus_physiology | 0.77768633 |
| 144 | MP0005266_abnormal_metabolism | 0.76566110 |
| 145 | MP0002078_abnormal_glucose_homeostasis | 0.75952100 |
| 146 | MP0003878_abnormal_ear_physiology | 0.75890233 |
| 147 | MP0005377_hearing/vestibular/ear_phenot | 0.75890233 |
| 148 | MP0000013_abnormal_adipose_tissue | 0.75844723 |
| 149 | MP0004085_abnormal_heartbeat | 0.75683810 |
| 150 | MP0001756_abnormal_urination | 0.75090636 |
| 151 | MP0002138_abnormal_hepatobiliary_system | 0.73742986 |
| 152 | MP0002971_abnormal_brown_adipose | 0.73301430 |
| 153 | MP0003436_decreased_susceptibility_to | 0.73121635 |
| 154 | MP0002722_abnormal_immune_system | 0.71852819 |
| 155 | MP0001663_abnormal_digestive_system | 0.71425158 |
| 156 | MP0003329_amyloid_beta_deposits | 0.71160910 |
| 157 | MP0006082_CNS_inflammation | 0.69751820 |
| 158 | MP0004019_abnormal_vitamin_homeostasis | 0.68909523 |
| 159 | MP0001849_ear_inflammation | 0.68581920 |
| 160 | MP0002295_abnormal_pulmonary_circulatio | 0.67207715 |
| 161 | MP0001958_emphysema | 0.66616460 |
| 162 | MP0002127_abnormal_cardiovascular_syste | 0.66284746 |
| 163 | MP0000371_diluted_coat_color | 0.66208102 |
| 164 | MP0005499_abnormal_olfactory_system | 0.65968953 |
| 165 | MP0005394_taste/olfaction_phenotype | 0.65968953 |
| 166 | MP0009765_abnormal_xenobiotic_induced | 0.63587963 |
| 167 | MP0003879_abnormal_hair_cell | 0.63342578 |
| 168 | MP0005535_abnormal_body_temperature | 0.61612416 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Sudden death (HP:0001699) | 4.79206010 |
| 2 | Eczematoid dermatitis (HP:0000976) | 4.56284999 |
| 3 | Exercise-induced muscle cramps (HP:0003710) | 4.41519554 |
| 4 | Palpitations (HP:0001962) | 4.37476882 |
| 5 | Muscle fiber splitting (HP:0003555) | 4.31016260 |
| 6 | Asymmetric septal hypertrophy (HP:0001670) | 4.19514314 |
| 7 | Recurrent bacterial skin infections (HP:0005406) | 4.02902613 |
| 8 | Recurrent abscess formation (HP:0002722) | 3.98670861 |
| 9 | Hyporeflexia of lower limbs (HP:0002600) | 3.93474248 |
| 10 | Exercise-induced myalgia (HP:0003738) | 3.84498079 |
| 11 | Vacuolated lymphocytes (HP:0001922) | 3.82171325 |
| 12 | Myositis (HP:0100614) | 3.78585874 |
| 13 | Loss of speech (HP:0002371) | 3.76757319 |
| 14 | Myoglobinuria (HP:0002913) | 3.74829788 |
| 15 | Ventricular tachycardia (HP:0004756) | 3.74245313 |
| 16 | Orchitis (HP:0100796) | 3.71916025 |
| 17 | Right ventricular cardiomyopathy (HP:0011663) | 3.70621162 |
| 18 | Recurrent gram-negative bacterial infections (HP:0005420) | 3.49722761 |
| 19 | Calf muscle hypertrophy (HP:0008981) | 3.46255309 |
| 20 | Retrobulbar optic neuritis (HP:0100654) | 3.36725169 |
| 21 | Optic neuritis (HP:0100653) | 3.36725169 |
| 22 | Dysostosis multiplex (HP:0000943) | 3.35186204 |
| 23 | Axonal loss (HP:0003447) | 3.28900956 |
| 24 | Increased cerebral lipofuscin (HP:0011813) | 3.28190270 |
| 25 | Stomatitis (HP:0010280) | 3.21779005 |
| 26 | Syncope (HP:0001279) | 3.21417194 |
| 27 | Amyloidosis (HP:0011034) | 3.19605970 |
| 28 | Nuclear cataract (HP:0100018) | 3.14148259 |
| 29 | Muscle hypertrophy of the lower extremities (HP:0008968) | 3.13383736 |
| 30 | Mediastinal lymphadenopathy (HP:0100721) | 3.12408149 |
| 31 | Disinhibition (HP:0000734) | 2.98272195 |
| 32 | Neurofibrillary tangles (HP:0002185) | 2.95193506 |
| 33 | Increased connective tissue (HP:0009025) | 2.91463848 |
| 34 | EMG: myopathic abnormalities (HP:0003458) | 2.90266645 |
| 35 | Ketoacidosis (HP:0001993) | 2.89842779 |
| 36 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.84185635 |
| 37 | Rhabdomyolysis (HP:0003201) | 2.82955759 |
| 38 | Atrial fibrillation (HP:0005110) | 2.80093080 |
| 39 | Difficulty climbing stairs (HP:0003551) | 2.78818549 |
| 40 | Lipoatrophy (HP:0100578) | 2.77535779 |
| 41 | Abnormality of glycolipid metabolism (HP:0010969) | 2.74373641 |
| 42 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.74373641 |
| 43 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.74373641 |
| 44 | Primary atrial arrhythmia (HP:0001692) | 2.74232892 |
| 45 | Mutism (HP:0002300) | 2.73870434 |
| 46 | Purpura (HP:0000979) | 2.73394474 |
| 47 | Glomerulonephritis (HP:0000099) | 2.72047619 |
| 48 | Increased serum ferritin (HP:0003281) | 2.71480259 |
| 49 | Hyperglycinuria (HP:0003108) | 2.70543730 |
| 50 | Ketosis (HP:0001946) | 2.70446434 |
| 51 | Abnormality of the calf musculature (HP:0001430) | 2.69946867 |
| 52 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.69556339 |
| 53 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.66667302 |
| 54 | Mucopolysacchariduria (HP:0008155) | 2.66667302 |
| 55 | Abnormality of fatty-acid metabolism (HP:0004359) | 2.65455943 |
| 56 | Supraventricular tachycardia (HP:0004755) | 2.62489459 |
| 57 | Increased IgE level (HP:0003212) | 2.61349611 |
| 58 | Hypoglycemic coma (HP:0001325) | 2.60968383 |
| 59 | Chronic obstructive pulmonary disease (HP:0006510) | 2.60257955 |
| 60 | Obstructive lung disease (HP:0006536) | 2.60257955 |
| 61 | Myotonia (HP:0002486) | 2.56231058 |
| 62 | Supraventricular arrhythmia (HP:0005115) | 2.55189231 |
| 63 | Gingivitis (HP:0000230) | 2.53872629 |
| 64 | Complement deficiency (HP:0004431) | 2.51143022 |
| 65 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.50106840 |
| 66 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.50106840 |
| 67 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.50106840 |
| 68 | Dilated cardiomyopathy (HP:0001644) | 2.49827403 |
| 69 | Hyperglycinemia (HP:0002154) | 2.45461817 |
| 70 | Abnormality of glycine metabolism (HP:0010895) | 2.44695523 |
| 71 | Abnormality of serine family amino acid metabolism (HP:0010894) | 2.44695523 |
| 72 | Muscle fiber inclusion bodies (HP:0100299) | 2.43138145 |
| 73 | Ventricular arrhythmia (HP:0004308) | 2.42518657 |
| 74 | Xanthomatosis (HP:0000991) | 2.42469778 |
| 75 | Difficulty running (HP:0009046) | 2.40598652 |
| 76 | Type 1 muscle fiber predominance (HP:0003803) | 2.40154857 |
| 77 | Hyperammonemia (HP:0001987) | 2.38945698 |
| 78 | Zonular cataract (HP:0010920) | 2.37887903 |
| 79 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.37624879 |
| 80 | Dicarboxylic aciduria (HP:0003215) | 2.37624879 |
| 81 | Vertebral compression fractures (HP:0002953) | 2.36774649 |
| 82 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.36552469 |
| 83 | Recurrent skin infections (HP:0001581) | 2.36157918 |
| 84 | Ulnar deviation of the wrist (HP:0003049) | 2.36132163 |
| 85 | Neuronal loss in central nervous system (HP:0002529) | 2.33959827 |
| 86 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 2.33948876 |
| 87 | Malnutrition (HP:0004395) | 2.33855183 |
| 88 | Keratoconjunctivitis sicca (HP:0001097) | 2.32302014 |
| 89 | Abnormality of complement system (HP:0005339) | 2.32196591 |
| 90 | Atrioventricular block (HP:0001678) | 2.30346415 |
| 91 | Autoimmune thrombocytopenia (HP:0001973) | 2.30344649 |
| 92 | Prolonged QT interval (HP:0001657) | 2.29299511 |
| 93 | Myocardial infarction (HP:0001658) | 2.28836325 |
| 94 | Pulmonary infiltrates (HP:0002113) | 2.27491514 |
| 95 | Spontaneous hematomas (HP:0007420) | 2.25360362 |
| 96 | Late onset (HP:0003584) | 2.24608078 |
| 97 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 2.24519784 |
| 98 | Muscle stiffness (HP:0003552) | 2.23211691 |
| 99 | Petechiae (HP:0000967) | 2.22795981 |
| 100 | Upper motor neuron abnormality (HP:0002127) | 2.22086347 |
| 101 | Cerebral inclusion bodies (HP:0100314) | 2.20434172 |
| 102 | Bundle branch block (HP:0011710) | 2.19699371 |
| 103 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 2.18066789 |
| 104 | Testicular atrophy (HP:0000029) | 2.17392222 |
| 105 | Abnormality of iron homeostasis (HP:0011031) | 2.16659519 |
| 106 | Interstitial pulmonary disease (HP:0006530) | 2.16244492 |
| 107 | Hepatosplenomegaly (HP:0001433) | 2.14805317 |
| 108 | Progressive neurologic deterioration (HP:0002344) | 2.14273672 |
| 109 | Hematochezia (HP:0002573) | 2.13371805 |
| 110 | Recurrent fungal infections (HP:0002841) | 2.12661318 |
| 111 | Abnormality of the nasal mucosa (HP:0000433) | 2.11944510 |
| 112 | Vasculitis (HP:0002633) | 2.11291433 |
| 113 | Systemic lupus erythematosus (HP:0002725) | 2.10403364 |
| 114 | Gout (HP:0001997) | 2.09734445 |
| 115 | Hypoalphalipoproteinemia (HP:0003233) | 2.09258442 |
| 116 | Urticaria (HP:0001025) | 2.09077379 |
| 117 | Keratoconjunctivitis (HP:0001096) | 2.07474848 |
| 118 | Respiratory insufficiency due to defective ciliary clearance (HP:0200073) | 2.07196465 |
| 119 | Hemoptysis (HP:0002105) | 2.07173040 |
| 120 | Areflexia of lower limbs (HP:0002522) | 2.07171254 |
| 121 | Pheochromocytoma (HP:0002666) | 2.07097598 |
| 122 | Apathy (HP:0000741) | 2.04396781 |
| 123 | Gastrointestinal infarctions (HP:0005244) | 2.04247593 |
| 124 | Foot dorsiflexor weakness (HP:0009027) | 2.03718408 |
| 125 | Retinal dysplasia (HP:0007973) | 2.02204770 |
| 126 | Heart block (HP:0012722) | 2.01705423 |
| 127 | Diminished motivation (HP:0000745) | 2.01278319 |
| 128 | Distal arthrogryposis (HP:0005684) | 2.01074506 |
| 129 | Ventricular fibrillation (HP:0001663) | 2.00071165 |
| 130 | Supranuclear gaze palsy (HP:0000605) | 1.99924956 |
| 131 | Meningitis (HP:0001287) | 1.99768862 |
| 132 | Abnormal atrioventricular conduction (HP:0005150) | 1.99761272 |
| 133 | Myopathic facies (HP:0002058) | 1.98575194 |
| 134 | Neoplasm of head and neck (HP:0012288) | 1.96691697 |
| 135 | Esophageal neoplasm (HP:0100751) | 1.96691697 |
| 136 | Distal lower limb muscle weakness (HP:0009053) | 1.96580287 |
| 137 | Conjunctival hamartoma (HP:0100780) | 1.96119060 |
| 138 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 1.95068787 |
| 139 | Protuberant abdomen (HP:0001538) | 1.94760285 |
| 140 | Cellulitis (HP:0100658) | 1.93626196 |
| 141 | Prolonged neonatal jaundice (HP:0006579) | 1.92431158 |
| 142 | Chronic bronchitis (HP:0004469) | 1.92324919 |
| 143 | Episodic fever (HP:0001954) | 1.91085597 |
| 144 | Athetosis (HP:0002305) | 1.90055557 |
| 145 | Polyneuropathy (HP:0001271) | 1.88676799 |
| 146 | Neuroendocrine neoplasm (HP:0100634) | 1.88205847 |
| 147 | Pathologic fracture (HP:0002756) | 1.88010898 |
| 148 | Abnormality of the foot musculature (HP:0001436) | 1.87556619 |
| 149 | Dementia (HP:0000726) | 1.87175817 |
| 150 | Global brain atrophy (HP:0002283) | 1.86901363 |
| 151 | Gangrene (HP:0100758) | 1.86828833 |
| 152 | Cerebral edema (HP:0002181) | 1.84857261 |
| 153 | Hepatic necrosis (HP:0002605) | 1.84132171 |
| 154 | Hyperlipoproteinemia (HP:0010980) | 1.83035005 |
| 155 | Progressive muscle weakness (HP:0003323) | 1.82889545 |
| 156 | Nemaline bodies (HP:0003798) | 1.81883643 |
| 157 | Acute encephalopathy (HP:0006846) | 1.80577075 |
| 158 | Pustule (HP:0200039) | 1.78597007 |
| 159 | Cervical subluxation (HP:0003308) | 1.78574194 |
| 160 | Restrictive lung disease (HP:0002091) | 1.78552647 |
| 161 | Beaking of vertebral bodies (HP:0004568) | 1.77586929 |
| 162 | Segmental peripheral demyelination/remyelination (HP:0003481) | 1.77406018 |
| 163 | Acne (HP:0001061) | 1.77391317 |
| 164 | Abnormality of macrophages (HP:0004311) | 1.77012286 |
| 165 | Hypergammaglobulinemia (HP:0010702) | 1.76581068 |
| 166 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 1.75911094 |
| 167 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 1.75834432 |
| 168 | Large for gestational age (HP:0001520) | 1.75585003 |
| 169 | Pulmonary embolism (HP:0002204) | 1.75507776 |
| 170 | Peripheral demyelination (HP:0011096) | 1.75228483 |
| 171 | Gingival bleeding (HP:0000225) | 1.75056034 |
| 172 | Increased CSF protein (HP:0002922) | 1.74803528 |
| 173 | Bulbar palsy (HP:0001283) | 1.74605481 |
| 174 | Epistaxis (HP:0000421) | 1.74044417 |
| 175 | Bone pain (HP:0002653) | 1.73758138 |
| 176 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.73583565 |
| 177 | Colitis (HP:0002583) | 1.72997673 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TRIB3 | 4.63791470 |
| 2 | BCKDK | 4.00597743 |
| 3 | PHKG1 | 3.82308773 |
| 4 | PHKG2 | 3.82308773 |
| 5 | TTN | 3.75232368 |
| 6 | RIPK4 | 2.80666565 |
| 7 | OBSCN | 2.61149477 |
| 8 | ERN1 | 2.59848935 |
| 9 | PRPF4B | 2.53237203 |
| 10 | BLK | 2.50202211 |
| 11 | MAPKAPK3 | 2.42072590 |
| 12 | PDK3 | 2.36777187 |
| 13 | PDK4 | 2.36777187 |
| 14 | MAP3K14 | 2.15491468 |
| 15 | PKN2 | 2.12198578 |
| 16 | MAP4K1 | 2.08151678 |
| 17 | LMTK2 | 1.98440564 |
| 18 | NME2 | 1.94685216 |
| 19 | NEK1 | 1.79192685 |
| 20 | MAP3K3 | 1.77449784 |
| 21 | EPHB1 | 1.76732245 |
| 22 | IRAK3 | 1.73349759 |
| 23 | ZAP70 | 1.68457594 |
| 24 | PDK2 | 1.68121874 |
| 25 | FGR | 1.65855191 |
| 26 | MATK | 1.63729529 |
| 27 | CAMK2D | 1.51845151 |
| 28 | ICK | 1.50358619 |
| 29 | IKBKE | 1.47725459 |
| 30 | WNK4 | 1.47569842 |
| 31 | MAP3K13 | 1.42094614 |
| 32 | CDC42BPA | 1.40982479 |
| 33 | JAK3 | 1.35344479 |
| 34 | IKBKB | 1.35196652 |
| 35 | TESK1 | 1.34342512 |
| 36 | MAP2K3 | 1.30555531 |
| 37 | RIPK1 | 1.29253128 |
| 38 | STK24 | 1.27180986 |
| 39 | MYLK | 1.24424622 |
| 40 | MOS | 1.23774182 |
| 41 | PAK3 | 1.23338661 |
| 42 | FES | 1.22371274 |
| 43 | PINK1 | 1.21797086 |
| 44 | MAPK15 | 1.21422426 |
| 45 | TNK2 | 1.20777357 |
| 46 | PRKD3 | 1.19584789 |
| 47 | ARAF | 1.19377334 |
| 48 | EEF2K | 1.17005953 |
| 49 | JAK1 | 1.08605871 |
| 50 | PIM2 | 1.06507062 |
| 51 | TESK2 | 1.04937183 |
| 52 | LRRK2 | 1.04891295 |
| 53 | TRPM7 | 1.02154901 |
| 54 | ILK | 1.01300213 |
| 55 | NTRK1 | 1.00702820 |
| 56 | STK38L | 0.99536881 |
| 57 | MUSK | 0.99485237 |
| 58 | GRK6 | 0.99478901 |
| 59 | CAMKK2 | 0.96426921 |
| 60 | DAPK3 | 0.95614351 |
| 61 | SIK1 | 0.95522275 |
| 62 | MARK2 | 0.95123123 |
| 63 | CAMK2G | 0.91454951 |
| 64 | MAP3K11 | 0.91294723 |
| 65 | SYK | 0.90223416 |
| 66 | CAMK1D | 0.89897239 |
| 67 | SIK3 | 0.88967815 |
| 68 | HCK | 0.87626047 |
| 69 | JAK2 | 0.85877186 |
| 70 | TBK1 | 0.85829731 |
| 71 | FLT3 | 0.85539543 |
| 72 | LYN | 0.85406502 |
| 73 | CSF1R | 0.82755952 |
| 74 | MAP2K6 | 0.82584401 |
| 75 | KIT | 0.81513333 |
| 76 | RPS6KA2 | 0.81233706 |
| 77 | TXK | 0.81052427 |
| 78 | MAPK7 | 0.80490607 |
| 79 | MARK3 | 0.80291009 |
| 80 | PDPK1 | 0.79561370 |
| 81 | MET | 0.79117928 |
| 82 | STK39 | 0.78648928 |
| 83 | PTK6 | 0.77343047 |
| 84 | PRKD2 | 0.76928137 |
| 85 | IRAK2 | 0.76316305 |
| 86 | MAP3K6 | 0.75246428 |
| 87 | TYK2 | 0.75179267 |
| 88 | BTK | 0.73684842 |
| 89 | EPHA2 | 0.72461882 |
| 90 | PRKD1 | 0.70752858 |
| 91 | CHUK | 0.70257571 |
| 92 | IRAK1 | 0.69538083 |
| 93 | MAP2K2 | 0.68558891 |
| 94 | PIK3CG | 0.67096534 |
| 95 | DYRK1B | 0.66740453 |
| 96 | LCK | 0.66109964 |
| 97 | BMPR2 | 0.65610467 |
| 98 | MAPK12 | 0.61901949 |
| 99 | FGFR4 | 0.60820889 |
| 100 | SIK2 | 0.59705517 |
| 101 | ACVR1B | 0.59326687 |
| 102 | MAP3K5 | 0.58451098 |
| 103 | DAPK2 | 0.57428580 |
| 104 | FER | 0.56798186 |
| 105 | STK38 | 0.56759513 |
| 106 | CAMK2B | 0.54797421 |
| 107 | MAP3K2 | 0.54237747 |
| 108 | HIPK2 | 0.52016007 |
| 109 | MAPK4 | 0.51261519 |
| 110 | RPS6KL1 | 0.50464907 |
| 111 | RPS6KC1 | 0.50464907 |
| 112 | CAMKK1 | 0.49526173 |
| 113 | EPHA3 | 0.48722464 |
| 114 | RPS6KA6 | 0.48157269 |
| 115 | MAPKAPK2 | 0.47898299 |
| 116 | TGFBR2 | 0.46557782 |
| 117 | PRKAA1 | 0.46349161 |
| 118 | MAP3K1 | 0.45211651 |
| 119 | IRAK4 | 0.44496043 |
| 120 | PAK4 | 0.44176615 |
| 121 | PRKG2 | 0.43759352 |
| 122 | MST1R | 0.43695934 |
| 123 | LIMK1 | 0.43008460 |
| 124 | PDK1 | 0.42513296 |
| 125 | MTOR | 0.42198941 |
| 126 | PRKAA2 | 0.41927152 |
| 127 | ERBB3 | 0.41501901 |
| 128 | INSRR | 0.41102854 |
| 129 | MAP3K7 | 0.40776567 |
| 130 | PDGFRA | 0.40038958 |
| 131 | PTK2B | 0.40013385 |
| 132 | GRK7 | 0.39922972 |
| 133 | DDR2 | 0.39428931 |
| 134 | AKT2 | 0.38621999 |
| 135 | STK10 | 0.38018740 |
| 136 | FYN | 0.36764889 |
| 137 | ABL2 | 0.35916775 |
| 138 | ROCK2 | 0.35305574 |
| 139 | ROCK1 | 0.35018003 |
| 140 | PRKACG | 0.33699495 |
| 141 | SGK3 | 0.33069802 |
| 142 | TYRO3 | 0.32374301 |
| 143 | BRAF | 0.31893251 |
| 144 | MAP2K1 | 0.30959774 |
| 145 | PTK2 | 0.30958263 |
| 146 | TAOK1 | 0.30815464 |
| 147 | NEK9 | 0.30500149 |
| 148 | MAPK11 | 0.30279445 |
| 149 | BMX | 0.30222137 |
| 150 | CSK | 0.28623567 |
| 151 | KSR2 | 0.28592251 |
| 152 | TAOK2 | 0.27285769 |
| 153 | CAMK1G | 0.26343162 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 3.96311454 |
| 2 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 3.46559257 |
| 3 | Olfactory transduction_Homo sapiens_hsa04740 | 3.28055436 |
| 4 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.81544954 |
| 5 | Propanoate metabolism_Homo sapiens_hsa00640 | 2.77053239 |
| 6 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.61600044 |
| 7 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.57946132 |
| 8 | Leishmaniasis_Homo sapiens_hsa05140 | 2.40104851 |
| 9 | Carbon metabolism_Homo sapiens_hsa01200 | 2.37615386 |
| 10 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.31491613 |
| 11 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 2.30080549 |
| 12 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.20770020 |
| 13 | Lysosome_Homo sapiens_hsa04142 | 2.19115496 |
| 14 | Other glycan degradation_Homo sapiens_hsa00511 | 2.14567930 |
| 15 | Malaria_Homo sapiens_hsa05144 | 2.06807376 |
| 16 | Pyruvate metabolism_Homo sapiens_hsa00620 | 2.01775066 |
| 17 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.99576271 |
| 18 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.97418730 |
| 19 | Pertussis_Homo sapiens_hsa05133 | 1.96123226 |
| 20 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 1.85965585 |
| 21 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.83353457 |
| 22 | Allograft rejection_Homo sapiens_hsa05330 | 1.80863060 |
| 23 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.78302226 |
| 24 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.74393920 |
| 25 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.65613253 |
| 26 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.65306356 |
| 27 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.61709668 |
| 28 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.58573693 |
| 29 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.57167815 |
| 30 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.55382331 |
| 31 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.51767852 |
| 32 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.51435509 |
| 33 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.47682663 |
| 34 | Salmonella infection_Homo sapiens_hsa05132 | 1.47252049 |
| 35 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.44640735 |
| 36 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.44380730 |
| 37 | Parkinsons disease_Homo sapiens_hsa05012 | 1.43862824 |
| 38 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.43802968 |
| 39 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.42963429 |
| 40 | Galactose metabolism_Homo sapiens_hsa00052 | 1.42870407 |
| 41 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.42522423 |
| 42 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.40142402 |
| 43 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.37348651 |
| 44 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.37338896 |
| 45 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.36101886 |
| 46 | Asthma_Homo sapiens_hsa05310 | 1.35488048 |
| 47 | Peroxisome_Homo sapiens_hsa04146 | 1.34226190 |
| 48 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 1.32523981 |
| 49 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.32066213 |
| 50 | Influenza A_Homo sapiens_hsa05164 | 1.31597355 |
| 51 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 1.29336397 |
| 52 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.28475686 |
| 53 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.27594801 |
| 54 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.24998532 |
| 55 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.23933457 |
| 56 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.21956379 |
| 57 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 1.19055812 |
| 58 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.18478445 |
| 59 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.15886240 |
| 60 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.15409811 |
| 61 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.15119076 |
| 62 | Histidine metabolism_Homo sapiens_hsa00340 | 1.13936826 |
| 63 | Sulfur relay system_Homo sapiens_hsa04122 | 1.13507999 |
| 64 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.13143781 |
| 65 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 1.12605485 |
| 66 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.11891842 |
| 67 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.11588980 |
| 68 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 1.11279762 |
| 69 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.11215914 |
| 70 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.11014869 |
| 71 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.10353597 |
| 72 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.09436906 |
| 73 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 1.08893199 |
| 74 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.08837238 |
| 75 | Viral myocarditis_Homo sapiens_hsa05416 | 1.07155627 |
| 76 | Amoebiasis_Homo sapiens_hsa05146 | 1.06741726 |
| 77 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.02691598 |
| 78 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.02331990 |
| 79 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.01143627 |
| 80 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 1.00730996 |
| 81 | Hepatitis C_Homo sapiens_hsa05160 | 1.00580770 |
| 82 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.98859951 |
| 83 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.97963418 |
| 84 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.97414897 |
| 85 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.96574980 |
| 86 | Measles_Homo sapiens_hsa05162 | 0.96322452 |
| 87 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.96180997 |
| 88 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.95562022 |
| 89 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.94463363 |
| 90 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.94084697 |
| 91 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.93701117 |
| 92 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.92710619 |
| 93 | Alzheimers disease_Homo sapiens_hsa05010 | 0.92024575 |
| 94 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.91638027 |
| 95 | Shigellosis_Homo sapiens_hsa05131 | 0.91338121 |
| 96 | Bladder cancer_Homo sapiens_hsa05219 | 0.87565933 |
| 97 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.86332514 |
| 98 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.85070339 |
| 99 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.84827263 |
| 100 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.83784265 |
| 101 | Hepatitis B_Homo sapiens_hsa05161 | 0.82700895 |
| 102 | Insulin resistance_Homo sapiens_hsa04931 | 0.82346899 |
| 103 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.82286513 |
| 104 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.82234995 |
| 105 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.80122844 |
| 106 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.79211214 |
| 107 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.78974129 |
| 108 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.77886907 |
| 109 | Apoptosis_Homo sapiens_hsa04210 | 0.76849628 |
| 110 | Phagosome_Homo sapiens_hsa04145 | 0.76685015 |
| 111 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.76116158 |
| 112 | Bile secretion_Homo sapiens_hsa04976 | 0.76075377 |
| 113 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.76030483 |
| 114 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.75570616 |
| 115 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.73422144 |
| 116 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.72916825 |
| 117 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.72363946 |
| 118 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.68547234 |
| 119 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.66711380 |
| 120 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.66115033 |
| 121 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.66068932 |
| 122 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.66029207 |
| 123 | Mineral absorption_Homo sapiens_hsa04978 | 0.64203999 |
| 124 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.63357681 |
| 125 | Legionellosis_Homo sapiens_hsa05134 | 0.62819032 |
| 126 | Endocytosis_Homo sapiens_hsa04144 | 0.62574441 |
| 127 | Prion diseases_Homo sapiens_hsa05020 | 0.59747615 |
| 128 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.59505730 |
| 129 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.59090837 |
| 130 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.58926081 |
| 131 | Huntingtons disease_Homo sapiens_hsa05016 | 0.58655330 |
| 132 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.57940485 |
| 133 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.53853271 |
| 134 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.53689997 |
| 135 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.52804494 |
| 136 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.51725753 |
| 137 | Metabolic pathways_Homo sapiens_hsa01100 | 0.50859814 |
| 138 | Platelet activation_Homo sapiens_hsa04611 | 0.50121840 |
| 139 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.49900029 |
| 140 | Tuberculosis_Homo sapiens_hsa05152 | 0.49069864 |
| 141 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.48185011 |
| 142 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.47996527 |
| 143 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.47603504 |
| 144 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.47391870 |
| 145 | Proteasome_Homo sapiens_hsa03050 | 0.45518772 |
| 146 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.45264577 |
| 147 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.44671333 |
| 148 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.42919388 |
| 149 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.42784764 |
| 150 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.41189707 |
| 151 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.40479240 |
| 152 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.40008489 |
| 153 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.39962174 |
| 154 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.38463974 |
| 155 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.38267363 |
| 156 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.36637115 |
| 157 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.35703214 |
| 158 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.34838472 |
| 159 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.34680602 |
| 160 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.34383102 |
| 161 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.33047597 |
| 162 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.32759306 |
| 163 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.32648272 |
| 164 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.32460247 |
| 165 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.32127398 |
| 166 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.31015981 |
| 167 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.30643294 |
| 168 | ABC transporters_Homo sapiens_hsa02010 | 0.30315512 |
| 169 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.29772139 |
| 170 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.28848656 |
| 171 | Insulin secretion_Homo sapiens_hsa04911 | 0.28185564 |
| 172 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.27808615 |
| 173 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.27319689 |
| 174 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.26135095 |
| 175 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.25204339 |

